Cleared Traditional

K202672 - Precision Delivery Infusion Set

K202672 is the FDA 510(k) clearance for Precision Delivery Infusion Set by Quest Medical, Inc.. It is a Class 2 General Hospital device (product code FPA) cleared through the Traditional 510(k) pathway after a 128-day FDA review.

K202672 · Quest Medical, Inc. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2021
Decision
128d
Days
Class 2
Risk

K202672 is an FDA 510(k) clearance for the Precision Delivery Infusion Set. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Quest Medical, Inc. (Allen, US). The FDA issued a Cleared decision on January 21, 2021 after a review of 128 days - within the typical 510(k) review window.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Quest Medical, Inc. devices

Submission Details

510(k) Number K202672 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 15, 2020
Decision Date January 21, 2021
Days to Decision 128 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
1d faster than avg
Panel avg: 129d · This submission: 128d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Peers - FPA Set, Administration, Intravascular

All 445
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K202672.
Needleless Connector
K210217 · Jiangsu Caina Medical Co.,Ltd · May 2021
Safety Subcutaneous Infusion Set
K201626 · Epic Medical Pte. , Ltd. · Mar 2021
Velano ExT Extension Set
K200439 · Velano Vascular · Feb 2021
NeutrArt
K201872 · Asset Medikal Tasarim As. · Jan 2021
Female Luer Lock Cap
K200425 · Medsafety Solutions, LLC · Oct 2020
MaxZero Extension Sets with Needle-Free Connector(s)
K193088 · Carefusion, Inc. · Oct 2020